FR2631830B1 - Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique - Google Patents

Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique

Info

Publication number
FR2631830B1
FR2631830B1 FR8806923A FR8806923A FR2631830B1 FR 2631830 B1 FR2631830 B1 FR 2631830B1 FR 8806923 A FR8806923 A FR 8806923A FR 8806923 A FR8806923 A FR 8806923A FR 2631830 B1 FR2631830 B1 FR 2631830B1
Authority
FR
France
Prior art keywords
therapeutics
concentrate
preparation
high purity
purity factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8806923A
Other languages
English (en)
Other versions
FR2631830A1 (fr
Inventor
Thierry Burnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LILLE TRANSFUSION SANGUINE
Original Assignee
LILLE TRANSFUSION SANGUINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LILLE TRANSFUSION SANGUINE filed Critical LILLE TRANSFUSION SANGUINE
Priority to FR8806923A priority Critical patent/FR2631830B1/fr
Priority to DE3877529T priority patent/DE3877529T2/de
Priority to ES88402643T priority patent/ES2045167T5/es
Priority to EP88402643A priority patent/EP0317376B2/fr
Priority to AT88402643T priority patent/ATE84543T1/de
Priority to DK198805877A priority patent/DK173859B1/da
Priority to NO884688A priority patent/NO179997C/no
Priority to JP63267004A priority patent/JP2768957B2/ja
Publication of FR2631830A1 publication Critical patent/FR2631830A1/fr
Priority to US07/683,109 priority patent/US5457181A/en
Application granted granted Critical
Publication of FR2631830B1 publication Critical patent/FR2631830B1/fr
Priority to GR930400157T priority patent/GR3006910T3/el
Priority to GR960401282T priority patent/GR3019900T3/el
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8806923A 1987-10-23 1988-05-25 Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique Expired - Lifetime FR2631830B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR8806923A FR2631830B1 (fr) 1988-05-25 1988-05-25 Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique
ES88402643T ES2045167T5 (es) 1987-10-23 1988-10-20 Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
EP88402643A EP0317376B2 (fr) 1987-10-23 1988-10-20 Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
AT88402643T ATE84543T1 (de) 1987-10-23 1988-10-20 Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung.
DE3877529T DE3877529T2 (de) 1987-10-23 1988-10-20 Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
NO884688A NO179997C (no) 1987-10-23 1988-10-21 Fremgangsmåte for fremstilling av terapeutisk anvendbart faktor IX-konsentrat med stor renhet
DK198805877A DK173859B1 (da) 1987-10-23 1988-10-21 Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner
JP63267004A JP2768957B2 (ja) 1987-10-23 1988-10-22 高純度のヒト因子ｉｘ濃縮物および他の血漿蛋白質およびそれらの治療学的使用
US07/683,109 US5457181A (en) 1987-10-23 1991-04-11 Preparation of a high-purity human factor IX concentrate and other plasmatic proteins and their therapeutic use
GR930400157T GR3006910T3 (en) 1987-10-23 1993-01-28 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins
GR960401282T GR3019900T3 (en) 1987-10-23 1996-05-13 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8806923A FR2631830B1 (fr) 1988-05-25 1988-05-25 Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique

Publications (2)

Publication Number Publication Date
FR2631830A1 FR2631830A1 (fr) 1989-12-01
FR2631830B1 true FR2631830B1 (fr) 1991-06-21

Family

ID=9366580

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8806923A Expired - Lifetime FR2631830B1 (fr) 1987-10-23 1988-05-25 Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique

Country Status (1)

Country Link
FR (1) FR2631830B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115814099B (zh) * 2022-12-19 2024-04-26 成都蓉生药业有限责任公司 一种人凝血因子ix的干热处理稳定剂及其制剂与制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
CA1288711C (fr) * 1986-01-06 1991-09-10 Kenneth J. Smith Produit sanguin therapeutique et methode de preparation

Also Published As

Publication number Publication date
FR2631830A1 (fr) 1989-12-01

Similar Documents

Publication Publication Date Title
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK441184A (da) Pyrethroid-holdige formlegemer, deres fremstilling og anvendelse
FR2606410B1 (fr) Imidazopyridines, leur preparation et leur application en therapeutique
FR2607505B1 (fr) Nouveaux derives de piperazinyl-1 pyrimidine, leur preparation et leur application en therapeutique et cosmetique
IL87089A0 (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
DK155489A (da) Umaettede n-benzopyranyllactamer, deres fremstilling og anvendelse
DK354687A (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK229189A (da) Modificerede blokpolymerisater, deres fremstilling og anvendelse
IL78357A0 (en) Nitrofuran derivatives,the preparation thereof and their application in therapy
NO865112D0 (no) Forbindelser med fungicid virkning, deres fremstilling og anvendelse i fungicide preparater.
ZA898480B (en) Phenyloxypropanolamine derivatives,their preparation and their application in therapeutics
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
FR2608160B1 (fr) Nouveaux derives peptidiques et leur application notamment en therapeutique
GB8926725D0 (en) Improvements in or relating to chairs
DK489889A (da) Dihydropyridinamider, deres fremstilling og anvendelse i laegemidler
FR2631830B1 (fr) Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique
FR2542745B1 (fr) Polysaccharide, sa preparation et son application en therapeutique
IL90000A0 (en) Benzothiazepin-4-one derivatives,their preparation and their application in therapy
ZA862321B (en) Use of efomycins as performance promoters in animals,efomycins and their preparation
DK10487A (da) 4-aminoaryldihydropyridinlactoner, deres fremstilling og anvendelse i laegemidler
DK592389A (da) Penemderivater, deres fremstilling og anvendelse
FR2544308B1 (fr) Ethines substituees, leur preparation et leur application en therapeutique
FR2600648B1 (fr) N-imidazolylmethyl-diphenylazomethines, leur preparation et leur application en therapeutique
DK625287D0 (da) 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse
FR2577550B1 (fr) Derives insatures cycloaliphatiques, leurs procedes de preparation et leur utilisation en therapeutique et cosmetique

Legal Events

Date Code Title Description
CP Supplementary certificate of protection filed

Free format text: PRODUCT NAME: FACTEUR IX; NAT. REGISTRATION NO/DATE: NL 19762 19941230; FIRST REGISTRATION:

Spc suppl protection certif: 95C0027

Filing date: 19950627

CP Supplementary certificate of protection filed

Free format text: 95C0027, 950627

CR Supplementary certificate of protection laid open to the public (eec regulation of 18 june 1992)

Free format text: 95C0027, 950627

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 95C0027, 950627, EXPIRES:20091230

CP Supplementary certificate of protection filed
CA Change of address

Spc suppl protection certif: 95C0027

CD Change of name or company name

Spc suppl protection certif: 95C0027

CL Concession to grant licenses
TP Transmission of property

Spc suppl protection certif: 95C0027